nivolumab
bms
['nivo', 'nivolumab', 'kcsm,(-skcsm)', 'rcc,(-irccs),(-srcc),(-urcc)', 'prosper,trial']
prosper rct at #esmo22 - the neoadjuvant/adjuvant #immunotherapy trial in rcc. nivolumab in high risk resectable #kidneycancer. n=819; no placebo arm, no diff in pfs, -ve trial, os not mature. more work to be done! #kcsm 
Radiation Oncologist at the Peter MacCallum Cancer Centre @petermaccc, Associate Professor University of Melbourne, Australia ????. Views are my own. #radonc